Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.

dont miss

Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.


  • Andrew Bateman PhD MCSP: Speaking at the European Neurological Convention

    Andrew Bateman PhD MCSP
    University of Essex, School of Health and Social Care

    Neuropsychological Rehabilitation Research: how to win funds and change services

  • Dr Elizabeth Iveson: Speaking at the European Neurological Convention

    Dr Elizabeth Iveson
    Lives On Medical

    From Secondary to Primary care and beyond.. Challenges in the longer term management and rehabilitation following Stroke and Acquired Brain Injury. Wh

  • Dr Najma Khan-Bourne: Speaking at the European Neurological Convention

    Dr Najma Khan-Bourne
    King’s College Hospital NHS Foundation Trust

    Neuropsychological evaluation and formulation in acute stroke rehabilitation

  • Dr. Stephen Barabas: Speaking at the European Neurological Convention

    Dr. Stephen Barabas
    K-Laser UK Ltd

    Class IV Therapy Laser for Neurorehabilitation and Pain Management

  • Dr Anita Rose: Speaking at the European Neurological Convention

    Dr Anita Rose
    The Raphael Hospital

    Mental Health and Brain Injury: Promoting mental wellbeing